CWM
PCVX icon

CIBC World Markets’s Vaxcyte PCVX Stock Holding History

CIBC World Markets’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$350K Buy
+7,575
New +$339K ﹤0.01% 904
2025
Q2 		$504K Sell
15,498
-12,056
-44% -$395K ﹤0.01% 872
2025
Q1 		$1.04M Buy
27,554
+15,934
+137% +$1.27M 0.01% 676
2024
Q4 		$951K Buy
+11,620
New +$1.15M 0.01% 621

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CIBC World Markets's PCVX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Vaxcyte (PCVX) in Q4 2025: 7,575 shares worth $350K. The stake represents ﹤0.01% of the portfolio and ranks #904 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in PCVX as recently as Q2 2025.

CIBC World Markets first reported a position in PCVX in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.04M in Q1 2025. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

  • CIBC World Markets held 7,575 shares of Vaxcyte worth $350K as of Q4 2025.
  • Vaxcyte was a new CIBC World Markets position in Q4 2025.
  • Vaxcyte made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #904 holding.
  • CIBC World Markets first reported a position in Vaxcyte in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Vaxcyte position peaked at $1.04M in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.